Amyloid Education Series
![](https://ccs.ca/wp-content/uploads/2024/06/Amyloid-EN.png)
Welcome to the Amyloid Education Series
The Canadian Cardiovascular Society is thrilled to present the launch of our new ‘Amyloid Education Series.’ With an aim to address the challenges posed by amyloid, this program will provide practical knowledge and tools that will empower healthcare professionals to effectively diagnose and manage patients with amyloid-related conditions.
This multi-pronged and multi-modal program includes three MOC Section 1 accredited webinars, and three MOC Section 3 accredited programs.
Program Chairs:
![](https://ccs.ca/wp-content/uploads/2024/06/Morant.png)
![](https://ccs.ca/wp-content/uploads/2023/04/Gupta.png)
Past Events:
Part 1: Detecting Cardiac Amyloidosis: A Diagnostic Odyssey
Date: June 05, 2024 from 8:00 p.m. to 9:00 p.m ET
Faculty: Dr. Margot Davis, Dr. Nathalie Ho, and Dr. Francois Tournoux
![](https://ccs.ca/wp-content/uploads/2022/09/logo-AstraZeneca.png)
![](https://ccs.ca/wp-content/uploads/2021/02/Pfizer_Logo_Color_CMYK-1024x423.png)
This program has received an educational grant from AstraZeneca and Pfizer. This program was developed by the Canadian Cardiovascular Society and was planned to achieve scientific integrity, objectivity, and balance.